Heterogeneous perception of the ethical legitimacy of unbalanced randomization by institutional review board members: a clinical vignette-based survey-Reference-Cited by-同舟云学术

Heterogeneous perception of the ethical legitimacy of unbalanced randomization by institutional review board members: a clinical vignette-based survey

Published:2018-08-14 Issue:1 Volume:19 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

Dibao-Dina Clarisse^ORCID,Caille Agnès,Giraudeau Bruno

Funder

The Ministry of Health, France

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s13063-018-2822-1.pdf

Reference17 articles.

1. Dibao-Dina C, Caille A, Sautenet B, Chazelle E, Giraudeau B. Reporting of the rationale for unequal randomization in clinical trials is rare: a systematic review of the literature. J Clin Epidemiol. 2014;67(10):1070–5.

2. Dumville JC, Hahn S, Miles JN, Torgerson DJ. The use of unequal randomisation ratios in clinical trials: a review. Contemp Clin Trials. 2006;27:1–12.

3. Kuznetsova OM, Tymofyeyev Y. Preserving the allocation ratio at every allocation with biased coin randomization and minimization in studies with unequal allocation. Stat Med. 2012;31:701–23.

4. Dibao-Dina C, Caille A, Giraudeau B. Unbalanced rather than balanced randomized controlled trials are more often positive in favor of the new treatment: an exposed and nonexposed study. J Clin Epidemiol. 2015;68(8):944–9. https://doi.org/10.1016/j.jclinepi.2015.03.007 .

5. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 1987;317(3):141–5.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design of placebo-controlled randomized trials of anticancer agents: Ethical considerations based on a review of published trials;Clinical Trials;2021-10-24

2. Most randomized controlled trials for psoriasis used placebo comparators despite the availability of effective treatments;Journal of Clinical Epidemiology;2021-05

3. Ethical Considerations for Pediatric Placebo-Controlled Trials: FDA Outcomes and Perspectives;Therapeutic Innovation & Regulatory Science;2020-09-08

4. Stakeholder perspectives on adaptive clinical trials: a scoping review;Trials;2020-06-17